ArticleeLife2018
The who, where and how of fusobacteria and colon cancer.
Article in eLife, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04223102 (Rectal Microbiome Variability Among Rectal Cancer Cohorts Including Complete Clinical Responders, Pathologic Responders, and Early Recurrence), which is not on this map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Rectal Microbiome Variability Among Rectal Cancer Cohorts Including Complete Clinical Responders, Pathologic Responders, and Early Recurrence
Who cites it
13 citing papers in PubMed.
- The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome.Nature medicine · 2026Trial
- Young-onset colorectal cancer.Nature reviews. Disease primers · 2023Review
- Gut microbiota from essential tremor patients aggravates tremors in mice.Frontiers in microbiology · 2023Article
- Creutzfeldt-Jakob Disease: Alterations of Gut Microbiota.Frontiers in neurology · 2022Article
- Association of Gut Microbiota and Biochemical Features in a Chinese Population With Renal Uric Acid Stone.Frontiers in pharmacology · 2022Article
- The fermented soy beverage Q-CAN® plus induces beneficial changes in the oral and intestinal microbiome.BMC nutrition · 2021Article
- The gut microbiome in sickle cell disease: Characterization and potential implications.PloS one · 2021Article
- Fusobacterium nucleatum Contributes to the Carcinogenesis of Colorectal Cancer by Inducing Inflammation and Suppressing Host Immunity.Translational oncology · 2019Review
- Modulating the microbiome to improve therapeutic response in cancer.The Lancet. Oncology · 2019Review
- Human Lung Microbiome on the Way to Cancer.Journal of immunology research · 2019Review
- Microbiome Dependent Regulation of TFrontiers in immunology · 2019Review
- Gut Microbiota, Fusobacteria, and Colorectal Cancer.Diseases (Basel, Switzerland) · 2018Review
- Article
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The association between the bacterium
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.